Vera Juan

CIK 00017554952 companiesHOUSTON, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001755495

Recent Transactions

44 trades

Award
Marker Therapeutics, Inc.$MRKR
Employee Stock Option (right to buy)
2025-10-31+250,000→ 250,000 total
Award
Marker Therapeutics, Inc.$MRKR
Employee Stock Option (right to buy)
2025-02-12+50,000→ 50,000 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-06-06+35,000→ 2,409,928 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-05-11+35,000→ 2,374,928 total
Award
Marker Therapeutics, Inc.$MRKR
Employee Stock Option (right to buy)
2023-05-10+100,000→ 100,000 total
Award
Marker Therapeutics, Inc.$MRKR
Employee Stock Option (right to buy)
2023-02-27+46,487→ 46,487 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2022-05-17+27,500→ 27,500 total
Tax Payment
Marker Therapeutics, Inc.$MRKR
Common Stock
2022-03-24$0.48/sh−33,465→ 2,671,845 total
Award
Marker Therapeutics, Inc.$MRKR
Common Stock
2022-03-24+140,823→ 2,705,310 total
Award
Marker Therapeutics, Inc.$MRKR
Employee Stock Option (right to buy)
2022-02-17+160,000→ 160,000 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2021-05-25+22,500→ 22,500 total
Purchase
Marker Therapeutics, Inc.$MRKR
Common Stock
2021-03-16$1.75/sh+571,428→ 2,564,487 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-03$38.22/sh−7,142→ 2,347,474 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-03$37.01/sh−1,300→ 2,354,616 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-03$38.63/sh−7,546→ 2,339,928 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-02$38.30/sh−9,001→ 2,357,719 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-02$37.28/sh−4,190→ 2,366,720 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-02$39.10/sh−1,803→ 2,355,916 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-01$38.73/sh−20,584→ 2,371,610 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-01$38.27/sh−11,570→ 2,392,194 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-01$39.53/sh−700→ 2,370,910 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-23$40.97/sh−600→ 2,403,764 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-23$40.13/sh−2,300→ 2,404,364 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-23$38.33/sh−1,125→ 2,411,489 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-23$39.11/sh−4,825→ 2,406,664 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-22$42.80/sh−11,050→ 2,412,994 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-22$43.40/sh−380→ 2,412,614 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-22$41.58/sh−2,891→ 2,424,044 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-19$41.79/sh−13,233→ 2,426,935 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-18$41.49/sh−3,710→ 2,440,168 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-18$39.48/sh−1,200→ 2,447,910 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-18$40.44/sh−4,032→ 2,443,878 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-17$40.00/sh−1,400→ 2,453,170 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-17$41.26/sh−4,060→ 2,449,110 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-17$38.71/sh−2,000→ 2,454,570 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-16$41.79/sh−9,434→ 2,457,536 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-16$42.53/sh−966→ 2,456,570 total
Award
Marker Therapeutics, Inc.$MRKR
Employee Stock Option (right to buy)
2021-02-10+140,000→ 140,000 total
Conversion
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2020-08-03+2,436,773→ 2,466,970 total
Conversion
Kalaris Therapeutics, Inc.$KLRS
Series A-3 Convertible Preferred Stock
2020-08-03−3,631,293→ 0 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2020-07-29+22,500→ 22,500 total
Award
Marker Therapeutics, Inc.$MRKR
Employee Stock Option (Right to Buy)
2020-03-10+26,600→ 26,600 total
Award
Marker Therapeutics, Inc.$MRKR
Employee Stock Option (Right to Buy)
2020-03-10+113,400→ 113,400 total
Award
Marker Therapeutics, Inc.$MRKR
Employee Stock Option (Right to Buy)
2018-10-19+500,000→ 500,000 total

Companies

Recent Filings

Address

C/O MARKER THERAPEUTICS, INC., 2450 HOLCOMBE BLVD, SUITE BCM-A, MS: BCM251

HOUSTON, TX, 77021

View on SEC.gov